Companies in the genetics sector developing innovative solutions and technologies.
Explore 352 recently funded genetics companies with verified founder contact information and fundraising data.
NorthLinks Bio is a clinical-stage biopharmaceutical company developing HEX17.
ChemT Biotechnology is an AI platform that researches and develops molecules for biotechnology manufacturers.
Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.
Gero is a biotechnology company that provides therapeutics against chronic diseases
FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
Radical Numerics develops AI for biological intelligence, aiming to enhance gene-editing tools through advanced models.
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.
Dioseve is a biotechnology company that produces egg cells using DIOLs to create more life possiblities.
SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel RNA-modulating drug candidates.
Artan Biotechnologies offers biotech R&D services and molecular tools for assays, nucleic acid engineering, and bioinformatics
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
Prenetics is a genetic and diagnostic health testing company that helps to identify health risks with the use of DNA sequencing technology.
Latus Bio develops gene therapy candidates, particularly for treating central nervous system (CNS) disorders using screened AAV capsids.
Entelo bio is a computational biotech company building the engine for functional cell profiling and novel target discovery.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
The genetics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Genetics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The genetics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 352 genetics companies tracked in the VCBacked database.
Companies in the genetics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting genetics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked